SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Yossi Rosman, Merav Lidar, Yehuda Shoenfeld, Antibiotic therapy in autoimmune disorders, Clinical Practice, 2014, 11, 1, 91

    CrossRef

  2. 2
    I. E. Sommer, R. van Westrhenen, M. J. H. Begemann, L. D. de Witte, S. Leucht, R. S. Kahn, Efficacy of Anti-inflammatory Agents to Improve Symptoms in Patients With Schizophrenia: An Update, Schizophrenia Bulletin, 2014, 40, 1, 181

    CrossRef

  3. 3
    Karina M. Mata, Cristiane Tefé-Silva, Elaine M. Floriano, Cleverson R. Fernandes, Elen Rizzi, Raquel F. Gerlach, Marc Q. Mazzuca, Simone G. Ramos, Interference of doxycycline pretreatment in a model of abdominal aortic aneurysms, Cardiovascular Pathology, 2014,

    CrossRef

  4. 4
    Sapna P. Sadarangani, Lynn L. Estes, James M. Steckelberg, Non–anti-infective Effects of Antimicrobials and Their Clinical Applications, Mayo Clinic Proceedings, 2014,

    CrossRef

  5. 5
    James R. O'Dell, Kelley's Textbook of Rheumatology, 2013,

    CrossRef

  6. 6
    T. Rath, O. Sander, A. Rubbert, Conventional disease-modifying antirheumatic drugs to treat rheumatoid arthritis, Drug Development Research, 2011, 72, 8
  7. 7
    Xavier Lévêque, Emanuele Cozzi, Philippe Naveilhan, Isabelle Neveu, Intracerebral xenotransplantation: recent findings and perspectives for local immunosuppression, Current Opinion in Organ Transplantation, 2011, 16, 2, 190

    CrossRef

  8. 8
    Christopher J Smith, Harlan Sayles, Ted R Mikuls, Kaleb Michaud, Minocycline and doxycycline therapy in community patients with rheumatoid arthritis: prescribing patterns, patient-level determinants of use, and patient-reported side effects, Arthritis Research & Therapy, 2011, 13, 5, R168

    CrossRef

  9. 9
    Angela Smith, Caroline Doré, Peter Charles, Alena Vallance, Tara Potier, Charles Mackworth-Young, Randomised Double-Blind Trial of Combination Antibiotic Therapy in Rheumatoid Arthritis, International Journal of Rheumatology, 2011, 2011, 1

    CrossRef

  10. 10
    R.S. Panush, The effects of doxycycline on reducing symptoms in knee osteoarthritis: results from a triple-blinded randomised controlled trial, Yearbook of Medicine, 2011, 2011, 12

    CrossRef

  11. 11
    Mohamed M. Thabet, Tom W.J. Huizinga, Rheumatology, 2011,

    CrossRef

  12. 12
    Norman T. Ilowite, Ronald M. Laxer, Textbook of Pediatric Rheumatology, 2011,

    CrossRef

  13. 13
    Pamela Mangat, Natalia Wegner, Patrick J Venables, Jan Potempa, Bacterial and human peptidylarginine deiminases: targets for inhibiting the autoimmune response in rheumatoid arthritis?, Arthritis Research & Therapy, 2010, 12, 3, 209

    CrossRef

  14. 14
    Delphine Michel-Monigadon, Véronique Nerrière-Daguin, Xavier Lévèque, Martine Plat, Eric Venturi, Philippe Brachet, Philippe Naveilhan, Isabelle Neveu, Minocycline Promotes Long-Term Survival of Neuronal Transplant in the Brain by Inhibiting Late Microglial Activation and T-Cell Recruitment, Transplantation, 2010, 89, 7, 816

    CrossRef

  15. 15
    Daniela Dalm, Gottfried J. Palm, Alexey Aleksandrov, Thomas Simonson, Winfried Hinrichs, Nonantibiotic Properties of Tetracyclines: Structural Basis for Inhibition of Secretory Phospholipase A2, Journal of Molecular Biology, 2010, 398, 1, 83

    CrossRef

  16. 16
    Michael G Feely, James R OʼDell, Update on the use of conventional disease-modifying antirheumatic drugs in the management of rheumatoid arthritis, Current Opinion in Rheumatology, 2010, 22, 3, 316

    CrossRef

  17. 17
    MIRELLA SALVATORE, BURT R. MEYERS, Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 2010,

    CrossRef

  18. 18
    Ted R. Mikuls, Jeffrey B. Payne, Richard A. Reinhardt, Geoffrey M. Thiele, Eileen Maziarz, Amy C. Cannella, V. Michael Holers, Kristine A. Kuhn, James R. O'Dell, Antibody responses to Porphyromonas gingivalis (P. gingivalis) in subjects with rheumatoid arthritis and periodontitis, International Immunopharmacology, 2009, 9, 1, 38

    CrossRef

  19. 19
    Mesut Ogrendik, Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: A 3-month, randomized, double-blind, placebo-controlled trial, Clinical Therapeutics, 2009, 31, 8, 1754

    CrossRef

  20. 20
    Alejandro Díaz-Borjón, Guidelines for the Use of Conventional and Newer Disease-Modifying Antirheumatic Drugs in Elderly Patients with Rheumatoid Arthritis, Drugs & Aging, 2009, 26, 4, 273

    CrossRef

  21. 21
    Mesut Ogrendik, Rheumatoid arthritis is linked to oral bacteria: etiological association, Modern Rheumatology, 2009, 19, 5, 453

    CrossRef

  22. 22
    Mesut Ogrendik, Rheumatoid arthritis is linked to oral bacteria: etiological association, Modern Rheumatology, 2009, 19, 5, 453

    CrossRef

  23. 23
    Suzan M. ATTAR, Tetracyclines: what a rheumatologist needs to know?, International Journal of Rheumatic Diseases, 2009, 12, 2
  24. 24
    Ronald F. van Vollenhoven, Treatment of rheumatoid arthritis: state of the art 2009, Nature Reviews Rheumatology, 2009, 5, 10, 531

    CrossRef

  25. 25
    Kevin D. Deane, Sterling G. West, Rheumatoid Arthritis, 2009,

    CrossRef

  26. 26
    Kenneth G. Saag, Gim Gee Teng, Nivedita M. Patkar, Jeremy Anuntiyo, Catherine Finney, Jeffrey R. Curtis, Harold E. Paulus, Amy Mudano, Maria Pisu, Mary Elkins-Melton, Ryan Outman, Jeroan J. Allison, Maria Suarez Almazor, S. Louis Bridges, W. Winn Chatham, Marc Hochberg, Catherine Maclean, Ted Mikuls, Larry W. Moreland, James O'dell, Anthony M. Turkiewicz, Daniel E. Furst, American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis, Arthritis Care & Research, 2008, 59, 6
  27. 27
    Joel M Kremer, COMET's path, and the new biologicals in rheumatoid arthritis, The Lancet, 2008, 372, 9636, 347

    CrossRef

  28. 28
    Brian T. Fay, Annemarie P. Whiddon, Susan Puumala, Natalie A. Black, James R. OʼDell, Ted R. Mikuls, Minocycline-Induced Hyperpigmentation in Rheumatoid Arthritis, JCR: Journal of Clinical Rheumatology, 2008, 14, 1, 17

    CrossRef

  29. 29
    B.H. Thiers, The Frequency and Distribution of Minocycline Induced Hyperpigmentation in a Rheumatoid Arthritis Population, Yearbook of Dermatology and Dermatologic Surgery, 2007, 2007, 207

    CrossRef

  30. 30
    Paul H. Gordon, Joseph Choi, Dan H. Moore, Robert G. Miller, Early Phase Trials of Minocycline in Amyotrophic Lateral Sclerosis, Progress in Neurotherapeutics and Neuropsychopharmacology, 2006, 1, 01, 63

    CrossRef

  31. 31
    Amy C Cannella, James R O???Dell, Early Rheumatoid Arthritis, Drugs, 2006, 66, 10, 1319

    CrossRef

  32. 32
    Ananth N Rao, Beena V. Shetty, D. M. Vasudevan, Positive influence of Methotrexate-Hydroxychloroquine combination on the expression of GM-CSF receptor on neutrophils of synovial fluid in rheumatoid arthritis, Indian Journal of Clinical Biochemistry, 2006, 21, 2, 49

    CrossRef

  33. 33
    James R. O'Dell, Jennifer R. Elliott, Jack A. Mallek, Ted R. Mikuls, Cynthia A. Weaver, Scott Glickstein, Kent M. Blakely, Raymond Hausch, Rob D. Leff, Treatment of early seropositive rheumatoid arthritis: Doxycycline plus methotrexate versus methotrexate alone, Arthritis & Rheumatism, 2006, 54, 2
  34. 34
    Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions, 2006,

    CrossRef

  35. 35
    D.C. Baptiste, K.J. Powell, C.A.B. Jollimore, C. Hamilton, T.L. Levatte, M.L. Archibald, B.C. Chauhan, G.S. Robertson, M.E.M. Kelly, Effects of minocycline and tetracycline on retinal ganglion cell survival after axotomy, Neuroscience, 2005, 134, 2, 575

    CrossRef

  36. 36
    Robin C Geletka, E William St Clair, Infliximab for the treatment of early rheumatoid arthritis, Expert Opinion on Biological Therapy, 2005, 5, 3, 405

    CrossRef

  37. 37
    P.M. Bartold, R.I. Marshall, D.R. Haynes, Periodontitis and Rheumatoid Arthritis: A Review, Journal of Periodontology, 2005, 76, 11-s, 2066

    CrossRef

  38. 38
    T. R. Mikuls, J. R. O'Dell, J. A. Stoner, L. A. Parrish, W. P. Arend, J. M. Norris, V. M. Holers, Association of rheumatoid arthritis treatment response and disease duration with declines in serum levels of IgM rheumatoid factor and anti–cyclic citrullinated peptide antibody, Arthritis & Rheumatism, 2004, 50, 12
  39. 39
    Richard S. Kalish, Susan Koujak, Minocycline inhibits antigen processing for presentation to human T cells: additive inhibition with chloroquine at therapeutic concentrations, Clinical Immunology, 2004, 113, 3, 270

    CrossRef

  40. 40
    Elsa Diguet, Christian E. Gross, François Tison, Erwan Bezard, Rise and fall of minocycline in neuroprotection: need to promote publication of negative results, Experimental Neurology, 2004, 189, 1, 1

    CrossRef

  41. 41
    Chi Chiu Mok, Anselm Mak, Therapeutic advances in rheumatoid arthritis, APLAR Journal of Rheumatology, 2004, 7, 1
  42. 42
    Alastair J.J. Wood, James R. O'Dell, Therapeutic Strategies for Rheumatoid Arthritis, New England Journal of Medicine, 2004, 350, 25, 2591

    CrossRef

  43. 43
    F. B. Mercado, R. I. Marshall, P. M. Bartold, Inter-relationships between rheumatoid arthritis and periodontal disease, Zusammenhänge zwischen rheumatoider Arthritis und Parodontalerkrankung – Eine Literaturübersicht, Relations entre arthrite rhumatoïde et maladie parodontale. Une revue, Journal of Clinical Periodontology, 2003, 30, 9
  44. 44
    Amy C. Cannella, James R. OʼDell, Is there still a role for traditional disease-modifying antirheumatic drugs (DMARDs) in rheumatoid arthritis?, Current Opinion in Rheumatology, 2003, 15, 3, 185

    CrossRef

  45. 45
    Jian Liu, Wanfen Xiong, Lisa Baca-Regen, Hideaki Nagase, B.Timothy Baxter, Mechanism of inhibition of matrix metalloproteinase-2 expression by doxycycline in human aortic smooth muscle cells, Journal of Vascular Surgery, 2003, 38, 6, 1376

    CrossRef

  46. 46
    Raphaela Goldbach-Mansky, Peter E. Lipsky, New Concepts in the Treatment of Rheumatoid Arthritis*, Annual Review of Medicine, 2003, 54, 1, 197

    CrossRef

  47. 47
    Patricia L Mottram, Past, present and future drug treatment for rheumatoid arthritis and systemic lupus erythematosus, Immunology and Cell Biology, 2003, 81, 5, 350

    CrossRef

  48. 48
    Robin Geletka, E.William St Clair, Treatment of early rheumatoid arthritis, Best Practice & Research Clinical Rheumatology, 2003, 17, 5, 791

    CrossRef

  49. 49
    T. Midtvedt, 2003,

    CrossRef

  50. 50
    Jennifer Hamilton, Vadivelu Saravanan, Advances in the treatment of rheumatoid arthritis: old versus new therapies, Expert Opinion on Pharmacotherapy, 2002, 3, 7, 845

    CrossRef

  51. 51
    Rodney E Willoughby, Karin B Nelson, Chorioamnionitis and brain injury, Clinics in Perinatology, 2002, 29, 4, 603

    CrossRef

  52. 52
    Amy K. Prall, G.Matthew Longo, William G. Mayhan, Eugene A. Waltke, Beverly Fleckten, Robert W. Thompson, B.Timothy Baxter, Doxycycline in patients with abdominal aortic aneurysms and in mice: Comparison of serum levels and effect on aneurysm growth in mice, Journal of Vascular Surgery, 2002, 35, 5, 923

    CrossRef

  53. 53
    Tamar A. Smith-Norowitz, Martin H. Bluth, Hazel Drew, Kevin B. Norowitz, Seto Chice, Vipin N. Shah, Maja Nowakowski, Alan S. Josephson, Helen G. Durkin, Rauno Joks, Effect of minocycline and doxycycline on IgE responses, Annals of Allergy, Asthma & Immunology, 2002, 89, 2, 172

    CrossRef

  54. 54
    Guidelines for the management of rheumatoid arthritis: 2002 Update , Arthritis & Rheumatism, 2002, 46, 2
  55. 55
    Staley A. Brod, Ingested Type I Interferon: A Potential Treatment for Autoimmunity, Journal of Interferon & Cytokine Research, 2002, 22, 12, 1153

    CrossRef

  56. 56
    Joseph F Collins, Sam T Donta, Charles C Engel, Joel B Baseman, Lisa L Dever, Thomas Taylor, Kathy D Boardman, Suzanne E Martin, Annette L Wiseman, John R Feussner, The Antibiotic Treatment Trial of Gulf War Veterans' Illnesses, Controlled Clinical Trials, 2002, 23, 3, 333

    CrossRef

  57. 57
    James R. O'Dell, COMBINATIONS OF CONVENTIONAL DISEASE-MODIFYING ANTIRHEUMATIC DRUGS, Rheumatic Disease Clinics of North America, 2001, 27, 2, 415

    CrossRef

  58. 58
    Johanne Martel-Pelletier, Dean J. Welsch, Jean-Pierre Pelletier, Metalloproteases and inhibitors in arthritic diseases, Best Practice & Research Clinical Rheumatology, 2001, 15, 5, 805

    CrossRef

  59. 59
    John P. Case, Old and New Drugs Used in Rheumatoid Arthritis: A Historical Perspective, American Journal of Therapeutics, 2001, 8, 3, 163

    CrossRef

  60. 60
    Ehab S. El Desoky, Pharmacotherapy of rheumatoid arthritis: an overview, Current Therapeutic Research, 2001, 62, 2, 92

    CrossRef

  61. 61
    Larry W. Moreland, POTENTIAL BIOLOGIC AGENTS FOR TREATING RHEUMATOID ARTHRITIS, Rheumatic Disease Clinics of North America, 2001, 27, 2, 445

    CrossRef

  62. 62
    E. William St.Clair, William E. Wilkinson, David S. Pisetsky, Daniel J. Sexton, Richard Drew, Virginia B. Kraus, Robert A. Greenwald, The effects of intravenous doxycycline therapy for rheumatoid arthritis: A randomized, double-blind, placebo-controlled trial, Arthritis & Rheumatism, 2001, 44, 5
  63. 63
    James R. O'Dell, Kent W. Blakely, Jack A. Mallek, P. James Eckhoff, Rob D. Leff, Steven J. Wees, Kelly M. Sems, Ana M. Fernandez, William R. Palmer, Lynell W. Klassen, Gail A. Paulsen, Claire E. Haire, Gerald F. Moore, Treatment of early seropositive rheumatoid arthritis: A two-year, double-blind comparison of minocycline and hydroxychloroquine, Arthritis & Rheumatism, 2001, 44, 10
  64. 64
    Anthony Chapman-Davies, Anka Lazarevic, Benign intracranial hypertension with minocycline therapy, Clinical and Experimental Optometry, 2000, 83, 5
  65. 65
    Jan K. Lacki, Management of the Patient with Severe Refractory Rheumatoid Arthritis, BioDrugs, 2000, 13, 6, 425

    CrossRef

  66. 66
       , minocycline, reumatoïde artritisMinocycline bij reumatoïde artritis, minocyclinereumatoïde artritis, Medisch-Farmaceutische Mededelingen, 2000, 38, 4, 73

    CrossRef

  67. 67
    John Brockbank, Dafna D Gladman, Psoriatic arthritis, Expert Opinion on Investigational Drugs, 2000, 9, 7, 1511

    CrossRef

  68. 68
    Graciela S Alarcón, Tetracyclines for the treatment of rheumatoid arthritis, Expert Opinion on Investigational Drugs, 2000, 9, 7, 1491

    CrossRef

  69. 69
    Kimberly Hamilton, E William St. Clair, Tumour necrosis factor-α blockade: a new era for effective management of rheumatoid arthritis, Expert Opinion on Pharmacotherapy, 2000, 1, 5, 1041

    CrossRef

  70. 70
    Francisco López-Jiménez, Máximo Brito, Y.Wady Aude, Phillip Scheinberg, Mariana Kaplan, Denise A. Dixon, Neil Schneiderman, Jorge F. Trejo, Luis Humberto López-Salazar, Ector Jaime Ramı́rez-Barba, Roberto Kalil, Carmen Ortiz, José Goyos, Alvaro Buenaño, Samer Kottiech, Gervasio A. Lamas, Update in Internal Medicine, Archives of Medical Research, 2000, 31, 4, 329

    CrossRef

  71. 71
    Sharon M. Moe, Anna M. Bailey, A coculture model of synoviocytes and bone for the evaluation of potential arthritis therapies, Journal of Pharmacological and Toxicological Methods, 1999, 41, 2-3, 127

    CrossRef

  72. 72
    Leonard H. Sigal, ANTIBIOTICS FOR THE TREATMENT OF RHEUMATOLOGIC SYNDROMES, Rheumatic Disease Clinics of North America, 1999, 25, 4, 861

    CrossRef

  73. 73
    James R. O'Dell, Anticytokine Therapy — A New Era in the Treatment of Rheumatoid Arthritis?, New England Journal of Medicine, 1999, 340, 4, 310

    CrossRef

  74. 74
    C Michael Stein, Theodore Pincus, Placebo-controlled studies in rheumatoid arthritis: ethical issues, The Lancet, 1999, 353, 9150, 400

    CrossRef

  75. 75
    Kenneth R. Wilske, Remodeling the therapeutic pyramid: evolving therapeutic strategies for rheumatoid arthritis, Japanese Journal of Rheumatology, 1999, 9, 1, 1

    CrossRef

  76. 76
    Ted Mikuls, Larry Moreland, The treatment of rheumatoid arthritis: A review of recent clinical trials, Current Rheumatology Reports, 1999, 1, 2, 135

    CrossRef

  77. 77
    Juan M. Angulo, Leonard H. Sigal, Luis R. Espinoza, Coexistent minocycline-induced systemic lupuserythematosus and autoimmune hepatitis, Seminars in Arthritis and Rheumatism, 1998, 28, 3, 187

    CrossRef

  78. 78
    Graciela S. Alarcón, MINOCYCLINE FOR THE TREATMENT OF RHEUMATOID ARTHRITIS, Rheumatic Disease Clinics of North America, 1998, 24, 3, 489

    CrossRef

  79. 79
    Bridget Griffiths, Andy Gough, Paul Emery, Minocycline-induced autoimmune disease: Comment on the editorial by Breedveld, Arthritis & Rheumatism, 1998, 41, 3
  80. 80
    Ferdinand C. Breedveld, Reply, Arthritis & Rheumatism, 1998, 41, 3
  81. 81
    James R. O'Dell, TRIPLE THERAPY WITH METHOTREXATE, SULFASALAZINE, AND HYDROXYCHLOROQUINE IN PATIENTS WITH RHEUMATOID ARTHRITIS, Rheumatic Disease Clinics of North America, 1998, 24, 3, 465

    CrossRef

  82. 82
    I. C. CHIKANZA, S. JAWED, D. NAUGHTON, D. R. BLAKE, Why Do We Need New Treatments for Rheumatoid Arthritis?, Journal of Pharmacy and Pharmacology, 1998, 50, 4
  83. 83
    Ferdinand C. Breedveld, Minocycline IN RHEUMATOID ARTHRITIS, Arthritis & Rheumatism, 1997, 40, 5
  84. 84
    JENNIFER M. GROSSMAN, ERNEST BRAHN, Rheumatoid Arthritis: Current Clinical and Research Directions, Journal of Women's Health, 1997, 6, 6, 627

    CrossRef